BioSpace News Archive

Policy

CHA Reacts to the Potential Devastating Impact of DOJ’s Decision in the Texas vs Azar Case

It is unconscionable and immoral for the Administration to support upending the entire health care system in the United States by supporting the District court ruling in the Texas vs Azar case at the expense of tens of millions of individuals’ and families’ lives and wellbeing.

March 27, 2019
·
2 min read
Deals

TITLE Boxing Club Sells Out Manhattan with Franchise Agreement; Looks to Expand Throughout East Coast

TITLE Boxing Club, the nation’s leading boutique boxing fitness franchise with more than 190 clubs open across the United States, announced today it has sold the franchise rights for all of Manhattan to Michael Tosto, current multi-unit franchisee

March 27, 2019
·
4 min read
Policy

Vizient Applauds Legislative Actions Aimed at Lowering Prescription Drug Costs

Vizient today announces its support of the House Energy and Commerce Subcommittee on Health for moving forward to advance a number of pieces of legislation that will begin to tackle out-of-control prescription drug spending.

March 27, 2019
·
2 min read
BioCapital

American Diabetes Association® Issues Critical Updates to the 2019 Standards of Medical Care in Diabetes

Updates are focused on new research findings impacting care for cardiovascular disease and chronic kidney disease in people with diabetes

March 27, 2019
·
6 min read
Business

Dermavant Sciences Announces Appointment of Cyril Allouche as Chief Financial Officer and Provides Recent Corporate Update

Allouche has over 20 years of combined experience in finance leadership, audit, and advisory roles, most recently serving as Principal Accounting Officer, Head of Finance, and Corporate Controller at Revance Therapeutics

March 27, 2019
·
3 min read
BioCapital

Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to strengthen agency’s safety requirements aimed at mitigating risks associated with transmucosal immediate-release fentanyl products

As the FDA continues to forcefully confront the opioid crisis, rationalizing prescribing practices and ensuring safe and appropriate use of these powerful medications remains a cornerstone of our efforts

March 27, 2019
·
8 min read
Business

Summit Therapeutics Reports Financial Results for the Fourth Quarter and Fiscal Year Ended 31 January 2019 and Operational Progress

• Focus on Improving Patient Outcomes for Serious Infectious Diseases • Conference Call Today at 12:00pm GMT / 8:00am EDT

March 27, 2019
·
7 min read
GENFIT Announces Pricing of Global Offering and Approval to List on Nasdaq Global Select Market

GENFIT is a French biopharmaceutical company focused on discovering and developing drug candidates and diagnostic solutions targeting liver diseases, in particular those of metabolic origin, and hepatobiliary diseases

March 27, 2019
·
9 min read
Enterome to present data on its innovative microbiome-derived molecular mimicry approach to cancer immunotherapy at AACR 2019

Enterome’s innovative approach is based on the concept of “molecular mimicry” whereby microbiome-derived bacterial antigens show molecular similarity with Tumor-associated Antigens and Tumor-specific Neoantigens

March 27, 2019
·
3 min read
Business

Konica Minolta Precision Medicine Announces the Formation of its Inaugural Scientific Advisory Board

Founded in late 2018, KMPM is dedicated to the advancement of precision medicine that takes into account individual variability in genes, environment, and lifestyle to more accurately predict, detect, treat and ultimately defeat disease.

March 27, 2019
·
4 min read